TCT 343: Long-Term Clinical Outcomes Following Intravascular Lithotripsy for Severe Coronary Artery Calcification in a Real-World Setting: A 12-Month Follow-Up From the REPLICA-EPIC18 Study
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - iVascular; Abbott; Medtronic; Bbraun
- Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation